-
1دورية أكاديمية
المؤلفون: M. B. Antsiferov, N. A. Demidov, N. A. Tabakaev
المصدر: Сахарный диабет, Vol 26, Iss 4, Pp 328-333 (2023)
مصطلحات موضوعية: diabetes mellitus, dapagliflozin, sglt-2 inhibitor, survival, life expectancy, Nutritional diseases. Deficiency diseases, RC620-627
وصف الملف: electronic resource
العلاقة: https://www.dia-endojournals.ru/jour/article/view/13010Test; https://doaj.org/toc/2072-0351Test; https://doaj.org/toc/2072-0378Test
-
2دورية أكاديمية
المصدر: Frontiers in Pharmacology, Vol 14 (2023)
مصطلحات موضوعية: continuous glucose monitoring, dapagliflozin, insulin, exposure-response model, SGLT-2 inhibitor, HbA1c, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2023.1229255/fullTest; https://doaj.org/toc/1663-9812Test
-
3دورية أكاديمية
المصدر: Терапевтический архив, Vol 94, Iss 10, Pp 1188-1196 (2022)
مصطلحات موضوعية: sglt-2 inhibitor, dapagliflozin, dapa-ckd study, chronic kidney disease, Medicine
وصف الملف: electronic resource
العلاقة: https://ter-arkhiv.ru/0040-3660/article/viewFile/108317/pdfTest; https://doaj.org/toc/0040-3660Test; https://doaj.org/toc/2309-5342Test
-
4دورية أكاديمية
المؤلفون: Boeder, Schafer, Edelman, Steven V
المصدر: Diabetes Obesity and Metabolism. 21(Suppl 2)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Clinical Trials and Supportive Activities, Pediatric, Diabetes, Patient Safety, Prevention, Clinical Research, Cardiovascular, Autoimmune Disease, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Metabolic and endocrine, Adult, Benzhydryl Compounds, Blood Glucose, Body Mass Index, Body Weight, Canagliflozin, Diabetes Mellitus, Type 1, Diabetic Ketoacidosis, Double-Blind Method, Drug Therapy, Combination, Female, Glucosides, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, canagliflozin, dapagliflozin, empagliflozin, SGLT-2 inhibitor, type 1 diabetes, Endocrinology & Metabolism, Clinical sciences
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/8sx858wsTest
-
5دورية أكاديمية
المؤلفون: Reddy M. , Venugopal, Sahayaraj, Christina, Haseena Begum, Shaik, Sonia S. , Sharon, Reddy Y. , Vijayabhaskar
المصدر: International Journal of Basic & Clinical Pharmacology; Vol. 12 No. 2 (2023): March-April 2023; 232-235 ; 2279-0780 ; 2319-2003
مصطلحات موضوعية: Dapagliflozin, SGLT-2 Inhibitor, Type-2DM, FBG, HbA1c
وصف الملف: application/pdf
العلاقة: https://www.ijbcp.com/index.php/ijbcp/article/view/5231/3498Test; https://www.ijbcp.com/index.php/ijbcp/article/view/5231Test
الإتاحة: https://doi.org/10.18203/2319-2003.ijbcp20230393Test
https://www.ijbcp.com/index.php/ijbcp/article/view/5231Test -
6دورية أكاديمية
المؤلفون: Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas
المصدر: Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-11 (2022)
مصطلحات موضوعية: SGLT-2 inhibitor, Empagliflozin, Dapagliflozin, Type 2 diabetes mellitus, Homoarginine, ADMA, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1475-2840Test
-
7دورية أكاديمية
المؤلفون: Zepeng Shi, Feng Gao, Wei Liu, Xuezhi He
المصدر: Frontiers in Cardiovascular Medicine, Vol 9 (2022)
مصطلحات موضوعية: heart failure, empagliflozin, dapagliflozin, SGLT-2 inhibitor, prognosis, Diseases of the circulatory (Cardiovascular) system, RC666-701
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fcvm.2022.869272/fullTest; https://doaj.org/toc/2297-055XTest
-
8دورية أكاديمية
المصدر: Bauersachs , J , de Boer , R A , Lindenfeld , J & Bozkurt , B 2022 , ' The year in cardiovascular medicine 2021 : heart failure and cardiomyopathies ' , European Heart Journal , vol. 43 , no. 5 , pp. 367-376 . https://doi.org/10.1093/eurheartj/ehab887Test
مصطلحات موضوعية: Heart failure, Epidemiology, Imaging, Biomarkers, Pharmacotherapy, Artificial intelligence, SGLT-2 inhibitor, Angiotensin receptor-neprilysin inhibitors, Activators of soluble guanylate cyclase, Device therapy, REDUCED EJECTION FRACTION, QUALITY-OF-LIFE, DOUBLE-BLIND, COVID-19, RISK, SACUBITRIL/VALSARTAN, DAPAGLIFLOZIN, OUTCOMES, EMPAGLIFLOZIN, INHIBITORS
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1093/eurheartj/ehab887Test
https://hdl.handle.net/11370/6d9e3f2c-e080-4381-9704-c1d9b1863790Test
https://research.rug.nl/en/publications/6d9e3f2c-e080-4381-9704-c1d9b1863790Test
https://pure.rug.nl/ws/files/216651966/ehab887.pdfTest -
9دورية أكاديمية
المؤلفون: Arne Gessner (11916637), Anna Gemeinhardt (11916640), Agnes Bosch (4711059), Dennis Kannenkeril (11916643), Christian Staerk (11823732), Andreas Mayr (406146), Martin F. Fromm (8694882), Roland E. Schmieder (7347371), Renke Maas (453805)
مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Physiology, Pharmacology, Marine Biology, Cancer, Chemical Sciences not elsewhere classified, SGLT-2 inhibitor, Empagliflozin, Dapagliflozin, Type 2 diabetes mellitus, Homoarginine, ADMA, SDMA, Cardiovascular disease
-
10دورية أكاديمية
المؤلفون: Dimitrios Patoulias, Christodoulos Papadopoulos, Ioanna Zografou, Alexandra Katsimardou, Asterios Karagiannis, Michael Doumas
المصدر: Medicina; Volume 58; Issue 9; Pages: 1167
مصطلحات موضوعية: SGLT-2 inhibitor, empagliflozin, dapagliflozin, arterial stiffness, pulse wave velocity, cardiovascular disease
وصف الملف: application/pdf
العلاقة: Endocrinology; https://dx.doi.org/10.3390/medicina58091167Test